U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07377071) titled 'Folate Treatment to Reduce Death Risk in the Year After Infection-Related Acute Kidney Injury' on Jan. 14.
Brief Summary: The goal of this clinical trial is to evaluate if taking folic acid (a form of vitamin B9) can help reduce the risk of death and improve kidney recovery in adults with acute kidney injury (AKI) caused by infections or sepsis.
The main question it aims to answer is: Does taking folic acid lower the chance of dying within one year for these patients? This study will also look at other important questions, such as whether folic acid helps kidneys recover faster (within 7 days), prevents long-term kidney problems (p...